Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
25.26
+0.81 (3.31%)
At close: Mar 28, 2024, 4:00 PM
25.47
+0.21 (0.83%)
After-hours: Mar 28, 2024, 5:29 PM EDT

Akero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-151.76-112.03-100.78-79.21-43.76-82.23-4.78
Depreciation & Amortization
0.260.260.240.21000
Share-Based Compensation
21.523.2410.056.021.770.120
Other Operating Activities
-15.37-3.9910.82.176.3676.970.18
Operating Cash Flow
-145.37-92.52-79.68-70.8-35.63-4.63-4.38
Capital Expenditures
000-0.15000
Acquisitions
00000-50
Change in Investments
-223.62-63.8342.28-9.61-71.5100
Investing Cash Flow
-223.62-63.8342.28-9.76-71.51-50
Share Issuance / Repurchase
339.09246.51.12203.0695.99-0.040
Debt Issued / Paid
151000000
Other Financing Activities
-0.78-0.86-0.520.05-85.055
Financing Cash Flow
353.32255.630.6203.1195.9985.015
Net Cash Flow
-15.6799.29-36.8122.54-11.1575.380.62
Free Cash Flow
-145.37-92.52-79.68-70.95-35.63-4.63-4.38
Free Cash Flow Per Share
-2.77-2.37-2.29-2.25-2.36-44.73-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).